Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
hot flashes
Biotech
Bayer’s hot flash drug hits goal in phase 3 breast cancer trial
The phase 3 breast cancer win potentially positions the German drugmaker to get the jump on Astellas’ rival drug Veozah.
Nick Paul Taylor
Jan 9, 2025 7:40am
KaNDy raises $32M for menopause study
Aug 29, 2018 9:15am
Trial suggests KaNDy’s menopause drug better than HRT
Jun 7, 2018 8:52am
NeRRe splits in two, carving out women’s health company
Sep 27, 2017 4:00am
